XT
QNCX icon

XTX Topco’s Quince Therapeutics QNCX Stock Holding History

XTX Topco’s Portfolio QNCX Stock Details QNCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.95K Buy
244
+182
+294% +$36.5K ﹤0.01% 3751
2025
Q4 		$41.8K Buy
+62
New +$31.2K ﹤0.01% 2879
2025
Q3 		– Sell
-113
Closed -$37.4K – 3136
2025
Q2 		$37.4K Buy
+113
New +$25.8K ﹤0.01% 2072
2024
Q4 		– Sell
-108
Closed -$16.7K – 2818
2024
Q3 		$16.7K Buy
108
+38
+54% +$5.45K ﹤0.01% 1867
2024
Q2 		$10.6K Buy
+70
New +$12.6K ﹤0.01% 1685
2024
Q1 		– Sell
-107
Closed -$22.5K – 2230
2023
Q4 		$22.5K Sell
107
-53
-33% -$10.6K ﹤0.01% 1347
2023
Q3 		$35.8K Buy
+160
New +$41.8K 0.01% 1315

Other funds holding QNCX

WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SC
Shay Capital New York $1.2B AUM 37.47% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.5B AUM 75.26% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

XTX Topco's QNCX Position: Q1 2026 in Review

XTX Topco increased its Quince Therapeutics (QNCX) stake by 294% in Q1 2026, buying an estimated $36.5K and bringing the position to 244 shares worth $4.95K. The position accounts for ﹤0.01% of the portfolio, ranked #3751.

XTX Topco first reported a position in QNCX in Q3 2023 and has held it in 7 quarters since. The position peaked at $41.8K in Q4 2025. 43 funds tracked by Wall St. Rank hold QNCX as of Q1 2026.

  • XTX Topco held 244 shares of Quince Therapeutics worth $4.95K as of Q1 2026.
  • XTX Topco bought 182 Quince Therapeutics shares in Q1 2026, an estimated $36.5K.
  • Quince Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q1 2026, its #3751 holding.
  • XTX Topco first reported a position in Quince Therapeutics in Q3 2023 and has held it in 7 quarters since.
  • XTX Topco's Quince Therapeutics position peaked at $41.8K in Q4 2025.
  • 43 funds tracked by Wall St. Rank held Quince Therapeutics as of Q1 2026.

Based on XTX Topco's 13F filing for Q1 2026, filed 15 May 2026.